The accompanying notes are an integral part of these consolidated financial statements.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1
NATURE OF BUSINESS
Nature of Operations
Flexpoint Sensor Systems, Inc. (the Company) is located in Draper, Utah. The Companys activities to date have included acquiring equipment and enhancing technology, obtaining financing, production and seeking long-term manufacturing contracts. The Companys operations are in designing, engineering, manufacturing and selling sensor technology and equipment using flexible potentiometer technology. Through December 31, 2017 the Company continued to manufacture products and sensors to fill customer orders and provide engineering and design work.
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and its wholly owned subsidiary, Flexpoint International, LLC. Intercompany transactions and accounts have been eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.
Cash and Cash Equivalents
Cash and cash equivalents are considered to be cash and a highly liquid security with original maturities of three months or less.
Fair Value Measurements -
The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk, including the partys own credit risk.
Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.
To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.
The carrying value of the Companys cash, accounts payable, short-term borrowings (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity.
The Company has classified the inputs used in valuing its derivative liabilities as level 3 inputs. The Company valued its derivatives using the binomial lattice model. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed below are that of volatility and market price of the underlying common stock of the Company.
24
Accounts Receivable
Trade accounts receivable are generally recorded at the time product is shipped or services are provided including any shipping and handling fees. Contracts associated with design and development engineering generally require a deposit of 50% of the quoted price prior to the commencement of work. The deposit is considered deferred income until the entire project is completed and accepted by the customer, at which time the entire contract price is billed to the customer and the deposit applied. The Company has established an allowance for bad debts based on a historical experience and an analysis of risk associated with the account balances. The balance in the allowance account was $145,194 and $102,140 in the years ended December 31, 2017 and 2016, respectively.
Inventories
Inventories are stated at the lower of cost or market. Cost is determined by using the first in, first out (FIFO) method.
Going Concern
The Company suffered losses of $1,083,642 and $2,093,184 and used cash in operating activities of $410,897 and $506,131 during the years ended December 31, 2017 and 2016, respectively. At December 31, 2017, the Company had an accumulated deficit of $27,306,453. These matters raise substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern.
From 2008 through 2017 the Company raised $5,379,278, which includes $420,000 raised in 2017, in additional capital, including accrued interest, through the issuance of long and short-term notes to related and other parties. All of the notes had an annual interest rate of 10% or 15% and were secured by the Companys business equipment. The notes also had a conversion feature for restricted common shares ranging from $0.05 to $0.20 per share with maturity dates of December 31, 2017 through December 31, 2018.
In June of 2016 a stock subscription in the amount of $9,958 was converted into 86,350 shares of restricted common stock.
In November of 2016, $335,018 in convertible notes and accrued interest were converted into 6,650,000 shares of restricted common stock at an average conversion price of approximately $0.05 per share.
In November 2017, $812,597 in convertible notes and accrued interest were converted into 14,500,000 shares of restricted common stock at an average conversion price of approximately $0.06 per share. The conversion resulted in a $115,183 gain recognized on the extinguishment of the debt.
Property and Equipment
Property and equipment are stated at cost. Additions and major improvements are capitalized while maintenance and repairs are charged to operations. Upon trade-in, sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized. Depreciation is computed using the straight-line method and is recognized over the estimated useful lives of the property and equipment, which range from three to ten years.
Valuation of Long-lived Assets
The carrying values of the Companys long-lived assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. Under similar analysis no impairment charge was taken during the year ended December 31, 2017. Impairment tests will be conducted on an annual basis and, should they indicate a carrying value in excess of fair value, additional impairment charges may be required.
Intangible Assets
Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the right to several patents and proprietary technology. Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology right, over their estimated useful lives, which range from 5 to 15 years. An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows. Under similar analysis there was no impairment charge taken during the year ended December 31, 2017.
Research and Development
Research and development costs are recognized as an expense during the period incurred, which is until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable.
Goodwill
Goodwill represents the excess of the Companys reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or at interim
25
periods when a triggering event occurs using a fair value approach. According to Accounting Standards Codification (or ASC) 350-20 Intangibles Goodwill and Other, a fair-value-based test is applied at the overall Company level. The test compares the fair value of the Company to the carrying value of its net assets. This test requires various judgments and estimates. The fair value of the Company is allocated to the Companys assets and liabilities based upon their fair values with the excess fair value allocated to goodwill. An impairment of goodwill is measured as the excess of the carrying amount of goodwill over the determined fair value.
Revenue Recognition
Revenue is generally recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers. Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer. Revenue from contracts to license technology to others is deferred until all conditions under the contracts are met and then recognized as licensing royalty revenue over the remaining term of the contracts. The Company does not provide extended warranties or guarantees on its products.
Stock-Based Compensation
The Company recognizes the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest. All share-based compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense in operations over the requisite service period. For the years ended December 31, 2017 and 2016, the Company recognized expense for stock-based compensation of $19,943 and $26,154, respectively.
Basic and Diluted Loss Per Share
Basic loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At December 31, 2017 and 2016, there were outstanding common share equivalents (options and convertible notes payable) which amounted to 16,644,625 and 23,399,094, respectively, of common stock. These common share equivalents were not included in the computation of diluted loss per share as their effect would have been anti-dilutive, thereby decreasing loss per common share.
Concentrations and Credit Risk -
The Company has a few major customers who represents a significant portion of revenue, accounts receivable and notes receivable. During the year ended December 31, 2017, a customer who is a toy manufacturer represented 29% of sales and represented 0% of accounts receivable. A customer who is utilizing our technology for commercialization in shoes represented 50% of accounts receivable and 100% of notes receivable at December 31, 2017. The Company has a strong relationship with these customers and does not believe this concentration poses a significant risk, as their products are based entirely on the Companys technologies. The Company has the option, under one of the notes receivable, to convert the principal and interest into equity of the customer
Income Taxes -
The Company accounts for income taxes in accordance with Statement of Financial Accounting Standards Board Accounting Codification (ASC) 740: Income Taxes. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets will be reflected on the balance sheet when it is determined that it is more likely than not that the asset will be realized
Recent Accounting Pronouncements
- In October 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2016-16, Income Taxes (Topic 740);
Intra-Entity Transfers of Assets Other Than Inventory
. This ASU requires entities to recognize the income tax consequences of many intercompany asset transfers at the transaction date. The seller and buyer will immediately recognize the current and deferred income tax consequences of an intercompany transfer of an asset other than inventory. The tax consequences were previously deferred until the asset is sold to a third part or recovered through use. This guidance will become effective on January 1, 2018.
In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230);
Classification of Certain Cash Receipts and Cash Payments
. This ASU addresses the following eight specific cash flow issues: Debt costs; settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; contingent consideration payments made after a business combination; proceeds from the settlement of insurance claims; proceeds from the settlement of corporate-owned life insurance policies (including bank-owned life insurance policies); distributions received from equity method investees; beneficial interests in securitization transactions; and separately identifiable cash flows and application of the predominance principle. This guidance will become effective on January 1, 2018. We do not expect the adoption of this ASU to have a material impact on our Consolidated Financial Statements.
In March 2016, the FASB issued ASU 2016-09, Compensation Stock Compensation (Topic 718);
Improvements to Employee Share-Based Payments Accounting
. The ASU changes how companies account for certain aspects of share-based payment
26
awards to employees, including the accounting for income taxes, forfeitures and statutory tax withholding requirements, as well as the classification of related matters in the statement of cash flows. This guidance will become effective January 1, 2017. We do not expect the adoption of this ASU to have a material impact on our Consolidated Financial Statements.
In February 2016, the FASB issued Accounting Standards Update ("ASU") 2016-02, L
eases.
This ASU requires lessees to put most leases on their balance sheets but recognize expenses in the income statement in a manner similar to current accounting treatment. This ASU changes the guidance on sale-leaseback transactions, initial direct costs and lease execution costs, and, for lessors, modifies the classification criteria and the accounting for sales-type and direct financing leases. For public business entities, this ASU is effective for annual periods beginning after December 15, 2018, and interim periods therein. Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. The Company is currently evaluating the impact of this ASU on its financial statements and disclosures.
In May 2014, the FASB issued ASU 2014-09,
Revenue from Contracts with Customers
(Topic 606). ASU 2014-09 is a comprehensive revenue recognition standard that will supersede nearly all existing revenue recognition guidance under current U.S. GAA{ and replace it with a principle based approach for determining revenue recognition. Under ASU 2017-09, revenue is recognized when a customer obtains control of promised goods or services and is recognized in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The FASB has recently issued ASU 2016-08, ASU 2016-10, ASU 2016-11, ASU 2016-12, ASU 2016-20 and ASU 2017-05, all of which clarify certain implementation guidance within ASU 2014-09. ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2017. The standard can be adopted either retrospectively to each prior reporting period presented of retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application. The Company will adopt the provisions of this statement in the first quarter of 2018 using the modified retrospective approach. We have assessed the impact adoption of this standard will have on our consolidated financial statements and related disclosures. Based on our assessment, the adoption of this standard will not have a material impact on our revenue recognition policies for either our products or services.
The Company has reviewed all other FASB-issued ASU accounting pronouncements and interpretations thereof that have effective dates during the period reported and in future periods. The Company has carefully considered the new pronouncements that alter previous GAAP and does not believe that any new or modified principles will have a material impact on the companys reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of the Companys financial management and certain standards are under consideration.
NOTE 2 NOTES RECEIVABLE
On June 23, 2010, the Company, along with David B. Beck, the Company's Director of Engineering, filed a complaint against R&D Products, LLC, Persimmon Investments, Inc. and Jules A. deGreef, the managing member of R&D Products, LLC. The complaint alleged that all of the intellectual properties owned by R&D Products and Mr. deGreef, specifically patented applications using Bend Sensor
®
technology that were filed jointly by Mr. Beck and Mr. deGreef, and later assigned solely to Mr. deGreef and R&D Products, are the property of the Company. The assignment by Mr. Beck of his rights in the patents and intellectual properties were improperly given and are the property of the Company. The Company believed that since Mr. Beck was an employee of the Company during the time that he became the primary creative force and inventor of the Bend Sensor
®
applications for R&D Products and Mr. deGreef, and the inventions and applications were created using Flexpoint resources, the Company claimed that such intellectual properties, patents, etc. filed by deGreef, Persimmon and R&D belong to Flexpoint and therefore has sought financial damages and ownership of all intellectual rights, patents and inventions created by Mr. Beck for deGreef, Persimmon and R&D Products.
On April 9, 2013, the parties of the above referenced litigation reached a favorable universal settlement agreement that reinforces the Company's rights to the intellectual properties and their related products, including the medical bed. In order to secure the Company had exclusive rights to all patents and intellectual properties associated with this litigation the Company advanced to Mr. deGreef $25,000 to bring current all of the filing and maintenance fees for the patents detailed in the law suit. The advance is secured by a promissory note with an annual interest rate of 10% to be paid no later than December 31, 2015. During 2016 the Company established an allowance of $31,813 for the note receivable from Mr. deGreef.
On April 1, 2015, the Company paid $51,157 for the assumption and assignment of a convertible promissory note receivable issued by Bend Tech, LLC (Bend Tech; one of the Companys customers see also Note 1,
Concentrations and Credit Risk
) and held by a third-party Bend Tech investor (the Investor). The note bears interest at the rate of 10% per annum and had a maturity date of April 1, 2015. The agreement allows the holder, at its option, to convert the note to a 5% ownership of Bend Tech. The Company elected to take assignment of those conversion rights, reaching an agreement with the Investor to pay the
27
principle and interest to the Investor at the due date. Bend Tech is expected to become a more significant customer of the Company as it begins its product introductions, and the Company elected to pay off the note and put itself in position to either receive the payment plus interest or convert the note into ownership of Bend Tech rather than have an outside investor make such conversion. As of the date of this report, the note is in default and the Company has not exercised its conversion option. The Company has recorded a bad debt expense charge for the full amount of the note. During 2016 the Company established an allowance of $54,993 for the note receivable from Bend Tech LLC.
NOTE 3 DERIVATIVE INSTRUMENTS
The derivative liability as of December 31, 2017, in the amount of $363,680 has a level 3 classification.
The following table provides a summary of changes in fair value of the Companys Level 3 financial liabilities as of December 31, 2017 and 2016:
|
|
|
|
|
|
|
| |
|
|
|
|
Total
|
|
Balance, December 31, 2015
|
|
|
|
|
-
|
|
Recognition of derivative liabilities upon initial valuation
|
|
|
|
|
40,892
|
|
Change in fair value of derivative liabilities
|
|
|
|
|
35,403
|
|
Conversions of derivative liabilities into equity instruments
|
|
|
|
|
-
|
|
Balance, December 31, 2016
|
|
|
|
|
76,295
|
|
Recognition of derivative liabilities upon initial valuation
|
|
|
|
|
226,651
|
|
Change in fair value of derivative liabilities
|
|
|
|
|
60,734
|
|
Conversions of derivative liabilities into equity instruments
|
|
|
|
|
-
|
|
Balance, December 31, 2017
|
|
|
|
|
363,680
|
|
During the year ended 2016 and 2017, the Company issued convertible promissory notes which are convertible into common stock. Due to the Companys lack of authorized shares necessary to settle all convertible instruments, in accordance with ASC 815-40-25, the Company determined that the conversion features related to these notes are derivative instruments since we do not have control to increase the number of authorized shares to settle all convertible instruments The accounting treatment of derivative financial instruments requires that the Company record fair value of the derivatives as of the inception date of debenture and to fair value as of each subsequent reporting date.
At December 31, 2017, the Company marked to market the fair value of the derivatives and determined a fair value of $363,680. The Company recorded a loss from change in fair value of derivatives of $60,734 for the year ended December 31, 2017. The fair value of the embedded derivatives was determined using binomial lattice model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 68.68% to 141.83%, (3) weighted average risk-free interest rate of 1.53% to 1.76% (4) expected life of 0.08 to 1.00 years, and (5) the quoted market price of the Companys common stock at each valuation date.
In accordance ASC 815-40, the Company has implemented a sequencing policy with respect to all outstanding convertible instruments. The Company evaluates its contracts based upon earliest issuance date.
Liabilities measured at fair value on a recurring basis are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
Derivative Liabilities
|
|
|
-
|
|
|
|
-
|
|
|
|
363,680
|
|
|
|
363,680
|
Total
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
363,680
|
|
|
$
|
363,680
|
NOTE 4 PROPERTY AND EQUIPMENT
Depreciation is computed using the straight-line method and is recognized over the estimated useful lives of the property and equipment, which range from three to ten years. Depreciation expense was $2,239 and $373 for the years ended December 31, 2017 and 2016, respectively and is included in the administrative and marketing expense on the statement of operations. No impairment was recognized during the twelve months ended December 31, 2017. Property and equipment at December 31, 2017 and 2016 consisted of the following:
28
|
|
| |
Property and Equipment
|
|
|
|
December 31,
|
2017
|
|
2016
|
|
|
|
|
Machinery and equipment
|
$ 543,249
|
|
$543,249
|
Office equipment
|
40,455
|
|
40,455
|
Furniture and fixtures
|
13,470
|
|
13,470
|
Software
|
416
|
|
416
|
|
|
|
|
Total Property and Equipment
|
597,590
|
|
597,590
|
|
|
|
|
Less: Accumulated depreciation
|
(589,006)
|
|
(586,767)
|
|
|
|
|
Net Property and Equipment
|
$ 8,584
|
|
$10,823
|
NOTE 5 GOODWILL AND INTANGIBLE ASSETS
Intangible Assets
The components of intangible assets at December 31, 2017 and 2016 were as follows:
|
|
|
|
| |
December 31, 2017
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
|
Net Carrying Amount
|
|
|
|
|
|
|
Patents
|
$174,963
|
|
$162,935
|
|
$12,028
|
Proprietary Technology
|
799,082
|
|
762,815
|
|
36,267
|
Total Amortizing Asset
|
$974,045
|
|
$925,750
|
|
$48,295
|
|
|
|
|
|
|
December 31, 2016
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
|
Net Carrying Amount
|
|
|
|
|
|
|
Patents
|
$173,313
|
|
$150,427
|
|
$22,886
|
Proprietary Technology
|
799,082
|
|
725,610
|
|
73,472
|
Total Amortizing Asset
|
$972,395
|
|
$876,037
|
|
$96,358
|
Patent amortization was $12,508 and $16,274 for the year ended December 31, 2017 and 2016, respectively. Amortization related to proprietary technology was $37,205 and $66,660 for the years ended December 31, 2017 and 2016. Patent and proprietary technology amortization is charged to operations.
Estimated aggregate amortization expense for each of the next three years is $30,290 in 2018 and $17,905 in 2019, at which time the patents will be fully amortized.
Goodwill
Goodwill represents the excess of the Companys reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or when a triggering event occurs. As described in ASU 2010-28, ASU 2011-08 and ASC 350-20-35, the Company has adopted the two step goodwill impairment analysis that includes quantitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two step goodwill impairment test. A fair-value-based test is applied at the overall Company level. The test compares the estimated fair value of the Company at the date of the analysis to the carrying value of its net assets. The analysis also requires various judgments and estimates, including general and macroeconomic conditions, industry and the Companys targeted market conditions, as well as relevant entity-specific events; such as a change in the market for the Companys products and services. After considering the qualitative factors that would indicate a need for interim impairment of goodwill and applying the two-step process described in ASC 350-20-35, paragraphs 4-13, management has determined that the value of Companys assets is not, more likely than not less than the carrying value of the Company including goodwill, and that no impairment charge needs be recognized during the reporting periods.
Upon emerging from bankruptcy protection in 2004, the Company engaged Houlihan Valuation Advisors, an independent valuation firm, to assess the fair value of the Companys goodwill, patents and other proprietary technology at the date of
29
emergence. The appraisal was completed during 2005. The Company continues to evaluate the fair value of its intangible assets using similar methods as those used by the valuation firm.
NOTE 6
INCOME TAXES
There was no provision for, or benefit from, income tax during the years ended December 31, 2017 and 2016 respectively. The components of the net deferred tax asset as of December 31, 2017 and 2016, including temporary differences and operating loss carry forwards that arose prior to reorganization from bankruptcy, are as follows:
|
| |
December 31
,
|
2017
|
2016
|
Operating loss carry forwards
|
$ 8,753,626
|
$ 8,062,514
|
Origination and amortization of interest on convertible notes
|
883,998
|
840,044
|
Allowance for doubtful accounts
|
76,537
|
61,814
|
Change in derivative liabilities
|
32,687
|
12,037
|
Options issued for services
|
653,545
|
646,764
|
Total Deferred Tax Assets
|
$ 10,350,393
|
$ 9,623,173
|
Valuation allowance
|
(10,350,393)
|
(9,623,173)
|
Net Deferred Tax Asset
|
$ --
|
$ --
|
Federal and state net operating loss carry forwards at December 31, 2017 and 2016 were $23,626,845 and $22,742,451, respectively. A portion of the net operating loss carry forwards includes losses incurred prior to February 24, 2004, when a change of greater than 50% in ownership of the Company occurred. As a result of the change of ownership, only a portion of the net operating loss carry forwards incurred prior to the change becomes available each year. The net operating loss carry forwards begin to expire in 2020.
The Company has evaluated Staff Accounting Bulletin No. 118 regarding the impact of the decreased tax rates of the Tax Cuts & Jobs Act. The schedules below reflect the Federal tax provision, deferred tax asset and valuation allowance using the new rates adjusted in the period of enactment.
The following is a reconciliation of the amount of benefit that would result from applying the federal statutory rate to pretax loss with the provision for income taxes for the years ended December 31, 2017 and 2016, respectively:
|
| |
For the Years Ended December 31
,
|
2017
|
2016
|
Tax at statutory rate (34%)
|
$ (368,438)
|
$ (711,683)
|
Options issued for services
|
6,781
|
8,892
|
Origination and amortization of interest on convertible notes
|
19,471
|
313,591
|
Allowance for doubtful accounts
|
14,723
|
61,814
|
Change in derivative liabilities
|
20,650
|
12,037
|
Change in valuation allowance
|
306,813
|
(315,348)
|
Provision for Income Taxes
|
$ --
|
$ --
|
Under FASB ASC 740-10-05-6, tax benefits are recognized only for the tax positions that are more likely than not be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50
percent likely to be realized upon ultimate settlement. Unrecognized tax benefits are tax benefits claimed in the company's tax return that do not meet these recognition and measurement standards.
The Company's policy is to recognize potential interest and penalties accrued related to unrecognized tax benefits with the income tax expense. For the years ended December 31, 2017, and 2016, the Company did not recognized any interest or penalties in its Statement of Operations, nor did it have any interest or penalties accrued in its Balance sheet at December 31, 2017 and 2016 relating to unrecognized benefits.
The tax years 2017, 2016, 2015 and 2014 remain open to examination for federal income tax purposes and by other major taxing jurisdictions to which the Company is subject.
30
On December 22, 2017, the Tax Cuts and Jobs Act pf 2017 (the Act) was signed into law making significant changes to the Internal Revenue Code of 1986, as amended (the Code). The Act reduces the federal corporate income tax rate from 35% to 21% effective for tax years beginning after December 31, 2017. ASC 470 requires the Company to remeasure the existing net deferred tax asset in the period of enactment. The Act also provides for immediate expensing of 100% or the costs of qualified property that is incurred and placed in service during the period from September 27, 2017 to December 31, 2022. Beginning January 1, 2023, the immediate expensing provision is phased down by 20% per year until it is completely phased out as of January 1, 2027. Additionally, effective January 1, 2018, the Act imposes possible limitations on the deductibility of interest expense. As a result of the provisions of the Act, the Companys deduction for interest expense could be limited in future years. The effects of other provisions of the Act are not expected to have a material impact on the Companys financial statements.
On December 22, 2017, the SEC staff issued Staff Accounting Bulletin No. 118 (SAB 118) to provide guidance on accounting for the tax effects of the Act. SAB 118 provides a measurement period that begins in the reporting period that includes the Acts enactment date and ends when an entity has obtained, prepared and analyzed the information that was needed in order to complete the accounting requirements under ASC 720. However, in no circumstance should the measurement period extend beyond one year from the enactment date. In accordance with SAB 118, a company must reflect in its financial statements the income tax effects of those aspects of the Act for which the accounting under ASC 740 is complete. SAB 118 provides that to the extent that a companys accounting for certain income tax effects of the Tax Act is incomplete but it is able to determine a reasonable estimate, it must record a provisional estimate in the financial statements.
The Company does not reflect a deferred tax asset in its financial statements, but includes that calculation and valuation in its footnotes. We are still analyzing the impact of certain provisions of the Act and refining our calculations. The Company will disclose any change in the estimates as it refines the accounting for the impact of the Act.
NOTE 7 CONVERTIBLE NOTES PAYABLE
Convertible Notes Payable Third Parties`
At January 1, 2016 there were three convertible notes outstanding with balances of $684,660, $123,797 and $160,000 with accrued interest of $3,001, $1,926 and $0, respectively. The first two notes bear interest at the rate of 10% per year (with a 15% default rate) and are convertible into shares of common stock at $0.05 per share. The third note bears interest at the rate of 10% per year (with a 10% default rate) and is convertible into shares of common stock at $0.07 per share.
During 2016 the Company secured additional financing to cover its ongoing operations in the amount of $460,000 by issuing various convertible notes bearing 10% annual interest (with a 15% default rate), secured by business assets and carrying exercise prices ranging between $0.06 and $0.07 per share. During 2016 the Company approved the conversion of the convertible note payable in the amount of $123,797 into 2.7 million shares of common stock.
During 2017 the Company secured additional financing to cover its ongoing operations in the amount of $380,000 by issuing various convertible notes bearing 10% annual interest (with a 15% default rate), secured by business assets and carrying exercise prices of $0.07 per share.
During 2017 the Company approved the conversion of the convertible note in the amount of $684,660 of principal and accrued interest of $127,939 into 14.5 million shares of common stock.
At December 31, 2017 there are notes outstanding with principal balances which total $880,000. Of the notes, $840,000 are convertible notes bearing a 10% annual rate of interest (with a 15% default rate) and are convertible into shares of common stock at the rate of $0.06 to $0.07 per share. The remaining $40,000 is a convertible note entered into on August 8, 2011 with a former Company Director. That note was due on December 31, 2015, and bears a default interest rate of 10%.
Convertible Note Payable Related Parties
On July 12, 2017 and September 1, 2017, the Company issued promissory notes for $30,000 and $10,000, respectively, to an officer of the Company. The notes bear interest at the rate of 8%, have a conversion feature for restricted common shares at $0.07 per share and maturity dates of December 31, 2018.
On July 12, 2017, an officer of the Company provided $7,000 to the Company under a line of credit. On September 23, 2017, the Company paid $7,000 to fully retire that obligation.
31
At December 31, 2017 the Convertible Notes Payable Related Parties principal was $114,514, the unamortized discount was $33,099 and interest accrued and unpaid was $6,809. The Company recorded interest expense of $1,907 during the year ended December 31, 2016 as it amortized the discount charges generated by the issuance of convertible notes payable.
On July 12, 2017 two officers assume responsibility for $54,513 of debt owed by the Company. The officers are making payments against those debts until such time that the Company is able to make the payments on its own behalf.
Due to the Companys lack of authorized shares necessary to settle these convertible instruments, in accordance with ASC 815-40-25, the Company determined that the conversion features related to these notes are derivative instruments since we do not have control to increase the number of authorized shares to settle these convertible instruments. The accounting treatment of derivative financial instruments requires that the Company record fair value of the derivatives as of the inception date of the Notes and to fair value as of each subsequent reporting date. At the inception of the Note, the Company determined the fair value of the derivatives were $363,680. The fair value of the embedded derivatives were determined using the Binominal Option Pricing Model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 68.68% to 141.83%, (3) weighted average risk-free interest rate of 1.53% to 1.76% (4) expected life of 0.08 to 1.00 years, and (5) the quoted market price of the Companys common stock at each valuation date.
NOTE 8
CAPITAL STOCK
Preferred Stock There are 1,000,000 shares of preferred stock with a par value of $0.001 per share authorized. At December 31, 2017 and 2016, there were no shares of preferred stock issued or outstanding.
Common Stock There are 100,000,000 shares of common stock with a par value of $0.001 per share authorized. During the year ended December 31, 2017, there were 14,500,000 shares of common stock issued. During the year ended December 31, 2016, there were 6,736,350 shares of common stock issued.
On November 7, 2017, the Board of Directors approved the conversion of $150,000 in convertible notes held by Liberty Partners, LLC, plus $26,769 in interest accrued and unpaid, to 3,500,000 shares of restricted common stock at an average conversion price of approximately $0.05 per share. On November 7, 2017, the Board of Directors approved the conversion of $160,000 in convertible notes held by Compass Equity Partners, LLC, plus $40,000 in interest accrued and unpaid, to 4,000,000 shares of restricted common stock at an average conversion price of approximately $0.05 per share. On November 7, 2017, the Board of Directors approved the conversion of $160,000 in convertible notes held by Maestro Investments LLC, plus $35,370 in interest accrued and unpaid, to 3,900,000 shares of restricted common stock at an average conversion price of approximately $0.05 per share. On November 7, 2017, the Board of Directors approved the conversion of $130,000 in convertible notes held by Compass Equity Partners LLC, plus $25,800 in interest accrued and unpaid, to 3,100,000 shares of restricted common stock at an average conversion price of approximately $0.05 per share.
In June 2016, the Board of Directors approved the issuance of 86,350 shares of restricted common stock to an employee to fully satisfy the terms of a stock subscription agreement.
In November 2016, the Board of Directors approved the conversion of $123,797 in convertible notes held by Liberty Partners, LLC, plus $12,821 in interest accrued and unpaid, to 2,700,000 shares of restricted common stock at an average price of approximately $0.05 per share.
In November 2016, the Board of Directors approved the conversion of $160,000 in convertible notes held by Compass Equity Partners, LLC, plus $38,400 in interest accrued and unpaid, to 3,950,000 shares of restricted common stock at an average price of approximately $0.05 per share.
NOTE 9
STOCK OPTION PLANS
On August 25, 2005, the Board of Directors of the Company approved and adopted the 2005 Stock Incentive Plan (the Plan). The Plan became effective upon its adoption by the Board and continued in effect for ten years, terminating on August 25,, 2015. This plan was approved by the stockholders of the Company at their annual meeting of shareholders on November 22, 2005. Under the Plan, the exercise price for all options issued will not be less than the average quoted closing market price of the Companys trading common stock for the thirty day period immediately preceding the grant date plus a premium of ten percent. The maximum aggregate number of shares that may be awarded under the plan is 2,500,000 shares.
The Company continues to utilize the Black-Scholes option-pricing model for calculating the fair value of the options granted as defined by ASC Topic 718, which is an acceptable valuation approach under ASC 718. This model requires the input of subjective assumptions, including the expected price volatility of the underlying stock.
32
On August 24, 2015, the Board of Directors approved the issuance of options to purchase 2,185,000 shares of the Companys common stock. Of the total issued, 1,960,000 options were issued to replace options held by directors and employees which were to expire and 225,000 options were issued to new employees. Of the options issued, 640,000 have an option price of $0.14 per share, 500,000 have an option price of $0.15 per share, 995,000 have an option price of $0.20 per share, and 50,000 have an option price of $0.25 per share. Options issued as replacement shall have immediate vesting terms. Options which are not replacements shall vest over a two year four month period in equal installments on the last day of 2015, 2016 and 2017, respectively.
Projected data related to the expected volatility and expected life of stock options is based upon historical and other information, and notably, the Company's common stock has limited trading history. Changes in these subjective assumptions can materially affect the fair value of the estimate, and therefore, the existing valuation models do not provide a precise measure of the fair value of the Company's employee stock options.
Between August 25, 2005 and December 31, 2017, the Company granted options to employees to purchase an aggregate 3,096,000 shares of common stock at exercise prices ranging from $0.15 to $2.07 per share. The options vest over three years and expire 10 years from the date of grant. The Company used the following assumptions in estimating the fair value of the options granted:
·
Market value at the time of issuance Range of $0.14 to 2.07
·
Expected term Range of 3.7 years to 10.0 years
·
Risk-free interest rate Range of 1.60% to 4.93%
·
Dividend yield 0%
·
Expected volatility 200% to 424%
·
Weighted-average fair value - $0.16 to $2.07
As of the years ended December 31, 2005 through 2017, the Company recognized a total of $2,443,768 of stock-based compensation expense, which includes charges of $19,943 in 2017 and $26,451 in 2016, leaving $0 and $19,943 in unrecognized expense as of December 31, 2017 and 2016, respectively. There were 2,185,000 and 2,185,000 employee stock options outstanding at December 31, 2017 and 2016, respectively.
A summary of all employee options outstanding and exercisable under the plan as of December 31, 2017, and changes during the year then ended is set forth below:
|
|
|
| |
Options
|
Shares
|
Weighted Average Exercise Price
|
Weighted Average Remaining Contractual Life (Years)
|
Aggregate Intrinsic Value
|
|
|
|
|
|
Outstanding at the beginning of period
|
2,185,000
|
$ 0.16
|
8.66
|
$ --
|
Granted
|
--
|
--
|
--
|
--
|
Expired
|
--
|
--
|
--
|
--
|
Forfeited
|
--
|
--
|
--
|
--
|
Outstanding at the end of Period
|
2,185,000
|
$ 0.17
|
7.65
|
$ --
|
Exercisable at the end of Period
|
2,185,000
|
$ 0.17
|
7.65
|
$ --
|
A summary of all employee options outstanding and exercisable under the plan as of December 31, 2016, and changes during the year then ended is set forth below:
33
|
|
|
| |
Options
|
Shares
|
Weighted Average Exercise Price
|
Weighted Average Remaining Contractual Life (Years)
|
Aggregate Intrinsic Value
|
|
|
|
|
|
Outstanding at the beginning of period
|
2,185,000
|
$ .16
|
9.66
|
$ --
|
Granted
|
--
|
--
|
--
|
--
|
Expired
|
--
|
--
|
--
|
--
|
Forfeited
|
--
|
--
|
--
|
--
|
Outstanding at the end of Period
|
2,185,000
|
$ 0.16
|
8.66
|
$ --
|
Exercisable at the end of Period
|
1,970,000
|
$ 0.16
|
8.65
|
$ --
|
NOTE 10
COMMITMENTS AND CONTINGENCIES
The Company currently occupies a manufacturing facility in Draper, Utah. The lease on the facility expired on December 31, 2014, at which time the Company entered into a three year extension which will expire on December 31, 2017. Either party may terminate the lease upon 90 day written notice. Under the terms of the lease the Company paid $8,950 per month in 2015 (the same rate as in 2014), paid $9,300 per month in 2016 and paid $9,600 per month in 2017.
NOTE 11 RELATED PARTY TRANSACTIONS
At December 31, 2017 and 2016, the Company had accounts payable of $0 and $1,420 to its Chief Executive Office for reimbursement of various operating expenses paid by him in the course of business.
On April 17, 2017, July 12, 2017, August 2, 2017, and September 1, 2017, the Company issued promissory notes for $20,000, $30,000, $10,000 and $10,000, respectively, to an officer of the Company. The notes bear interest at the rate of 8%, have a conversion feature for restricted common shares at $0.07 per share. The April 17 and August 2, 2017 notes have maturity dates of December 31, 2017. The July 12 and September 1, 2017 notes have maturity dates of December 31, 2018.
On July 1, 2016 and September 22, 2016, the Company issued two promissory notes for $10,000 each to an officer of the Company. The notes bear interest at the rate of 10%, have a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2016.
NOTE 12 - SUBSEQUENT EVENTS
The Company entered into a new convertible promissory note for up to $100,000 from a third party on January 31, 2018. The note has an annual interest rate of 10% and is secured by the Companys equipment. The note has a conversion feature for restricted common shares at $0.07 per share and a maturity date of July 31, 2018. The Company drew $40,000 against that note on February 23, 2018.
34